Luigi Formisano: Predicting response and guides treatment in cutaneous squamous cell carcinoma
Luigi Formisano, Associate Professor of Medical Oncology at the University of Naples Federico II, shared an article by him and colleagues on LinkedIn, adding:
“What a fantastic way to kick off the year!
Our latest work, ‘Early assessment of IL8 and PD1+ Treg predicts response and guides treatment monitoring in cemiplimab-treated cutaneous squamous cell carcinoma‘, is finally out!
A huge congratulations to our two brilliant researchers, Daniela Esposito and Fabiana Napolitano for leading this study, and a heartfelt thanks to my dear friend and incredible scientist, Giuseppe Ercolano for the collaboration.
This is just the beginning—more exciting research is on the way!
Check out the full article here.”
Authors: Daniela Esposit, Fabiana Napolitan, Daniela Claudia Maresca, Marcella Scala, Annarita Amat, Stefania Belli, Claudia Maria Ascione, Angela Vallefuoc, Giovanna Attanasi, Fabio Somma, Angela Ianaro, Daniela Russo, Silvia Varricchio, Massimo Mascolo, Claudia Costa, Alessia Villani, Massimiliano Scalvenzi, Gianfranco Orlandino, Teresa Troiani, Alberto Servetto, Roberto Bianco1, Giuseppe Ercolano and Luigi Formisano.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023